Athira Pharma (ATHA) began trading on the Nasdaq on Fri 18 Sept 20

• Note: Rebranded to LeonaBio (LONA) in 2026 alongside a strategic shift toward oncology and specialized therapeutics.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019.

• Sector(s): Healthcare
• Industry: Biotechnology
• Full Time Employees: 63
• Incorporated in 2011 
• Headquartered in Bothell, Washington
• https://www.athira.com